Ledger.Open graph →
SEC Form D · Amendment · filed October 31, 2013

Cancer Prevention Pharmaceuticals, Inc

Offering
$6.0M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TUCSON, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Daniel Donovan · Tucson, AZDirectorEugene W. Gerner · Tucson, AZExec · DirectorFrank Meyskens · Irvine, CADirectorJeffrey E. Jacob · Tucson, AZExec · DirectorRichard Love · Scottsdale, AZDirectorDavid M. Lorenz · Mercer Island, WAExec · DirectorRick Persaud · New York, NYDirectorBehzad Khosrowshahi · Toronto, Ontario, CanadaExec · DirectorAli Hedayat · London, United KingdomDirectorAli Seirafi · Geneva, V8Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗